Disease-modifying treatment of asthma: role of omalizumab

G. A. Novik; S. N. Avdeev; Yu. V. Solovkina

PULMONOLOGIYA
Russian Pulmonology Journal

ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)

User

eng | рус

PULMONOLOGIYA

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Novik G.A., Avdeev S.N., Solovkina Yu.V. Disease-modifying treatment of asthma: role of omalizumab. PULMONOLOGIYA. 2020;30(6):822-830. (In Russ.) https://doi.org/10.18093/0869-0189-2020-30-6-822-830

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Aleksandr G. Chuchalin

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

G. A. Novik
Saint-Petersburg State Pediatric Medical University, Healthcare Ministry of Russia
Russian Federation

Gennadiy A. Novik - Doctor of Medicine, Professor, Head of I.M.Vorontsov Pediatric diseases Department, Faculty of Postgraduate and Additional Professional Education.

Ul. Litovskaya 2, St. Petersburg, 194100

S. N. Avdeev
I.M. Sechenov First Moscow State Medical University (Sechenov University), Healthcare Ministry of Russia
Russian Federation

Sergey N. Avdeev - Doctor of Medicine, Professor, Corresponding Member of Russian Academy of Sciences, Head of Department of Pulmonology.

Ul. Trubetskaya 8, build. 2, Moscow, 119991; tel.: (495) 395-63-93

Yu. V. Solovkina
Novartis Pharma Limited Liability Company
Russian Federation

Yuliya V. Solovkina - Candidate of Medicine, Senior Medical Adviser, “Novartis Pharma” Limited Liability Company.

72/3 Leningradskiy pr., 125315, Moscow; tel.: (495) 660-75-09

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

PULMONOLOGIYA

For citations:

Cookies policy